Incyte Corporation INCY
$ 75.88
-0.33%
Quarterly report 2024-Q3
added 10-29-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Herve Hoppenot |
Employees in the company |
1 456 |
Shares |
224 M |
Market Cap[1] |
$ 17 B |
EBITDA (LTM) |
$ 600 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.